Myelofibrosis on 18F-FDG-PET/CT in a case suspicious for post-transplant lymphoproliferative disorder.
Recent studies have advocated the utility of fluorine-18 fluorodeoxyglucose-positron emission tomography (18)F-FDG-PET imaging in evaluation of various hematological disorders. We report a case of a 61-year-old man with clinical suspicion of post-transplant lymphoproliferative disorder (PTLD) where (18)F-FDG-PET/CT (computerized tomography) was helpful in identifying myelofibrosis. This paper aims to reveal the potential diagnostic value of PET/CT as an imaging modality in the evaluation of myelofibrosis.
Khanna
Vineet
V
Division of Nuclear Medicine, Department of Radiology, University of Pittsburgh Medical Center, Pittsburgh, PA 15213, USA.
Nama
Sharanya
S
Tailor
Rajiv
R
Muthukrishnan
Ashok
A
D003937:Diagnosis, Differential; D019788:Fluorodeoxyglucose F18; D016027:Heart Transplantation / Q000009:adverse effects* / Q000000981:diagnostic imaging; D006801:Humans; D054066:Leukemia, Large Granular Lymphocytic / Q000000981:diagnostic imaging / Q000209:etiology; D008297:Male; D008875:Middle Aged; D049268:Positron-Emission Tomography / Q000379:methods*; D055728:Primary Myelofibrosis / Q000175:diagnosis* / Q000209:etiology*; D019275:Radiopharmaceuticals; D013382:Subtraction Technique; D014057:Tomography, X-Ray Computed / Q000379:methods*
D019275:Radiopharmaceuticals; D019788:Fluorodeoxyglucose F18